These data suggest that induction of senescence through ribociclib is accompanied by a decreased responsiveness to various compounds, analogous to our previous observations on glucocorticoid receptor-mediated growth arrest induction in lung cancer [30]. Here, NR3C1 is linked to lung carcinoma.